stockportfolio.pro
Stocks / TNDM vs WVE
TNDM vs WVE
Tandem Diabetes Care, Inc. and Wave Life Sciences Ltd. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Tandem Diabetes Care, Inc. (TNDM) | Wave Life Sciences Ltd. (WVE) | |
|---|---|---|
| Market cap | $1.1B | $1.1B |
| Revenue (latest FY) | $1.01B | $42.73M |
| Net income (latest FY) | $-204.71M | $-204.38M |
| Revenue growth (5y CAGR) | 15.3% | 16.3% |
| Net margin | -20.2% | -478.3% |
| Return on equity | -131.9% | -39.4% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 1 | 0 |
| Positive free cash flow | No | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open TNDM — free Open WVE — freeFrequently asked questions
Which is bigger, TNDM or WVE?
Wave Life Sciences Ltd. is larger by market capitalization — $1.1B versus $1.1B.
Which grows faster, TNDM or WVE?
Over the last five fiscal years, Wave Life Sciences Ltd. grew revenue faster — 16.3%/yr versus 15.3%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.